Provided by Tiger Fintech (Singapore) Pte. Ltd.

EVEREST MED

47.650
+0.2000.42%
Volume:2.94M
Turnover:140.44M
Market Cap:15.58B
PE:-13.45
High:49.100
Open:47.300
Low:46.600
Close:47.450
Loading ...

Company Profile

Company Name:
EVEREST MED
Exchange:
SEHK
Establishment Date:
2017
Employees:
665
Office Location:
CITIC Pacific Plaza, 16/F,1168 West Nanjing Road,Jing’an District,Shanghai,China
Zip Code:
200041
Phone:
- -
Fax:
- -
Introduction:
Everest Medicines Ltd is a biopharmaceutical company primarily engaged in the discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines. The Company has built a product pipeline across renal, anti-infective, and autoimmune diseases. The Company’s products portfolio includes Nefecon (TARPEYO) using in the renal therapeutic area, XERAVA (eravacycline) using in the treatment of infections caused by susceptible gram-positive, gram-negative and anaerobic pathogens including those multidrug resistant isolates and other products. The Company conducts its business in the domestic and overseas markets.

Directors

Name
Position
FU Wei
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
HE Ying
Executive Director
LUO Yong Qing
Executive Director
LI YIFAN
Independent Director,Member of the Nomination Committee,Audit Committee Chairman
JIANG Shi Dong
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Member
XU Hai Yin
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
CAO Ji Zhe
Director
FENG Hong Gang
Director

Shareholders

Name
Position
LUO Yong Qing
CEO
HE Ying
General Manager,CFO
LIU Qi Hua
Corporate Secretary
YANG Jing Hang
Corporate Secretary
YANG Wei
Chief Science Officer
Jason Brown
Other Senior Executives
LIU Xu Xin
Other Senior Executives